Jan Skvarka, Ph.D., MBA
Board Member
Monte Rosa Therapeutics, Inc. (GLUE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jan Skvarka, Ph.D., MBA
Jan Skvarka, Ph.D., MBA is recorded as Board Member at Monte Rosa Therapeutics, Inc. (GLUE). Monte Rosa Therapeutics, Inc. reported in an 8-K filed March 23, 2023 that Jan Skvarka, Ph.D., MBA was appointed Class I director, effective March 23, 2023.
“On March 22, 2023, upon the recommendation of the Compensation, Nomination, and Corporate Governance Committee of the Board of Directors (the “Board”) of Monte Rosa Therapeutics, Inc. (the “Company”), the Board appointed Jan Skvarka, Ph.D., MBA to join the Board, effective as of March 23, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-03-23–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Monte Rosa Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Ajim Tamboli CFO
- Jennifer Champoux COO
- Sharon Townson CTO
- Philip Nickson General Counsel
- Matthew Bowen Chief Accounting Officer
- Andrew Schiff Board Member
- Anthony M. Manning, Ph.D. Board Member
- Anthony Manning Board Member
- Chandra P. Leo Board Member
- Eric A. Hughes, M.D., Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.